Biotech
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 12/27/12 -- Abattis Bioceuticals Corp. ("Abattis") (CNSX: FLU)(PINKSHEETS: ATTBF) is pleased to announce that the Company has entered into an ...
WEST LAFAYETTE, IN: WEST LAFAYETTE, IN -- (Marketwire) -- 12/27/12 -- (NASDAQ: BASI) today announced financial results for the fourth quarter and year ended September 30, 2012.Interim President & CEO and CFO Jacquel ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 12/27/12 -- Functional Technologies Corp. (TSX VENTURE: FEB)(OTCQX: FEBTF) (the "Company") today reported operational and financial results f ...
BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 12/24/12 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to tr ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 12/21/12 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced fiscal 2013 second quarter financial results today for the three and six months ...
SEATTLE, WA: SEATTLE, WA -- (Marketwire) -- 12/21/12 -- (NASDAQ: ATOS), The Breast Health Company™, announced today that Christopher S. Destro has joined the Company as Vice President of Sales and Marketing, re ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 12/21/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced that the Company has entered into a Clinical ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 12/21/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA), based on the ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 12/20/12 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today a ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 12/20/12 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS) announced that the Company's shareholders approved a special resolution today at the Special Meet ...
SEATTLE, WA: Prepares for National Roll Out of ForeCYTE Breast Health Test for Breast Cancer Risk Assessment ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 12/20/12 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of canc ...
LAVAL, QUEBEC: Active pharmaceutical ingredient to be manufactured at ProMetic's Laval, Quebec facility ...
PALATINE, IL: Request to Commence Clinical Investigation ...
DENVER, CO: DENVER, CO -- (Marketwire) -- 12/20/12 -- (OTCBB: OMBP), a biopharmaceutical company focused on the development of alternative uses of Alpha-1 antitrypsin (AAT) for the treatment of a variety of indi ...
PARSIPPANY, NJ: SOLO-1 Trial Meets All Protocol-Specified Endpoints; One Single Intravenous Dose of Oritavancin Is Non-Inferior to Twice-Daily Vancomycin Intravenous Dosing for 7-10 Days ...
CHAPEL HILL, NC: CHAPEL HILL, NC -- (Marketwire) -- 12/19/12 -- (OTCQB: CWNM) is pleased to announce that its (CDDT) has the potential to revolutionize the manner in which we take oral medication.Crown's CDDT i ...
MONTREAL, CANADA: Topline results anticipated in the first calendar quarter of 2013 ...
